Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 108
Filtrer
1.
Nat Commun ; 15(1): 6215, 2024 Jul 23.
Article de Anglais | MEDLINE | ID: mdl-39043664

RÉSUMÉ

Integrating genomics and histology for cancer prognosis demonstrates promise. Here, we develop a multi-classifier system integrating a lncRNA-based classifier, a deep learning whole-slide-image-based classifier, and a clinicopathological classifier to accurately predict post-surgery localized (stage I-III) papillary renal cell carcinoma (pRCC) recurrence. The multi-classifier system demonstrates significantly higher predictive accuracy for recurrence-free survival (RFS) compared to the three single classifiers alone in the training set and in both validation sets (C-index 0.831-0.858 vs. 0.642-0.777, p < 0.05). The RFS in our multi-classifier-defined high-risk stage I/II and grade 1/2 groups is significantly worse than in the low-risk stage III and grade 3/4 groups (p < 0.05). Our multi-classifier system is a practical and reliable predictor for recurrence of localized pRCC after surgery that can be used with the current staging system to more accurately predict disease course and inform strategies for individualized adjuvant therapy.


Sujet(s)
Néphrocarcinome , Tumeurs du rein , Récidive tumorale locale , Humains , Néphrocarcinome/génétique , Néphrocarcinome/anatomopathologie , Tumeurs du rein/génétique , Tumeurs du rein/anatomopathologie , Tumeurs du rein/chirurgie , Mâle , Femelle , Récidive tumorale locale/génétique , Adulte d'âge moyen , Sujet âgé , Pronostic , Génomique/méthodes , Adulte , Stadification tumorale , Apprentissage profond , Survie sans rechute
2.
Int J Biol Macromol ; 274(Pt 1): 133281, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38906358

RÉSUMÉ

In this study, a novel adsorbent, A-PEI/CS-Cu2+, was developed by crosslinking polyethyleneimine/chitosan hydrogel with acrolein and loading it with copper ions. The adsorption process of A-PEI/CS-Cu2+ on the anionic dye acid yellow 36 (AY36) was investigated by kinetic, isothermal and thermodynamic modeling. It was noteworthy that A-PEI/CS-Cu2+ exhibited rapid adsorption with a 90 % removal rate achieved within just 5 min, which was much faster than the adsorption rate of A-PEI/CS without load of copper ions and showed its potential for rapid adsorption applications. The maximum adsorption capacity for AY36 could reach up to 3114 mg g-1. In addition, the high concentration of saline wastewater was found to have almost no effect on the adsorption reaction in the salt effect test experiment. In five desorption-regeneration cycle experiments, the sample exhibited good recyclability and regeneration performance. The driving force of the adsorption process mainly originated from the electrostatic interaction, hydrogen bonding, and intermolecular interaction, in which the addition of copper ions led to the enhancement of the electrostatic interaction and chelation between A-PEI/CS-Cu2+ and AY36. Overall, the findings suggest the excellent potential of A-PEI/CS-Cu2+ for rapid and efficient adsorption, as well as its suitability for practical applications in wastewater treatment.


Sujet(s)
Acroléine , Chitosane , Cuivre , Hydrogels , Polyéthylèneimine , Polluants chimiques de l'eau , Chitosane/composition chimique , Cuivre/composition chimique , Polyéthylèneimine/composition chimique , Adsorption , Hydrogels/composition chimique , Polluants chimiques de l'eau/composition chimique , Cinétique , Acroléine/composition chimique , Composés azoïques/composition chimique , Thermodynamique , Anions/composition chimique , Purification de l'eau/méthodes , Agents colorants/composition chimique , Eaux usées/composition chimique , Ions/composition chimique , Concentration en ions d'hydrogène
3.
Chem Sci ; 15(21): 8156-8162, 2024 May 29.
Article de Anglais | MEDLINE | ID: mdl-38817557

RÉSUMÉ

The first straightforward strategy for the synthesis of 1,4-dicarbonyl Z-alkenes has been developed via an electrochemical cross-coupling reaction of sulfoxonium ylides and alkynes with water. The metal-free protocol showed an easy-to-handle nature, good functional group tolerance, and high Z-stereoselectivity, which is rare in previous cases. The proposed reaction mechanism was convincingly established by carrying out a series of control experiments, cyclic voltammetry experiments, and density functional theory (DFT) studies.

4.
Nat Commun ; 15(1): 2551, 2024 Mar 21.
Article de Anglais | MEDLINE | ID: mdl-38514606

RÉSUMÉ

Eukaryotic initiation translation factor 3 subunit h (EIF3H) plays critical roles in regulating translational initiation and predicts poor cancer prognosis, but the mechanism underlying EIF3H tumorigenesis remains to be further elucidated. Here, we report that EIF3H is overexpressed in colorectal cancer (CRC) and correlates with poor prognosis. Conditional Eif3h deletion suppresses colorectal tumorigenesis in AOM/DSS model. Mechanistically, EIF3H functions as a deubiquitinase for HAX1 and stabilizes HAX1 via antagonizing ßTrCP-mediated ubiquitination, which enhances the interaction between RAF1, MEK1 and ERK1, thereby potentiating phosphorylation of ERK1/2. In addition, activation of Wnt/ß-catenin signaling induces EIF3H expression. EIF3H/HAX1 axis promotes CRC tumorigenesis and metastasis in mouse orthotopic cancer model. Significantly, combined targeting Wnt and RAF1-ERK1/2 signaling synergistically inhibits tumor growth in EIF3H-high patient-derived xenografts. These results uncover the important roles of EIF3H in mediating CRC progression through regulating HAX1 and RAF1-ERK1/2 signaling. EIF3H represents a promising therapeutic target and prognostic marker in CRC.


Sujet(s)
Tumeurs colorectales , Système de signalisation des MAP kinases , Humains , Animaux , Souris , Phosphorylation , Transformation cellulaire néoplasique/génétique , Carcinogenèse , Voie de signalisation Wnt , Facteur-3 d'initiation eucaryote/génétique , Facteur-3 d'initiation eucaryote/métabolisme , Tumeurs colorectales/anatomopathologie , Mitogen-Activated Protein Kinase Kinases/métabolisme , Lignée cellulaire tumorale , Prolifération cellulaire/génétique , Régulation de l'expression des gènes tumoraux , Protéines adaptatrices de la transduction du signal/métabolisme
5.
Cell Oncol (Dordr) ; 47(4): 1277-1294, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38393513

RÉSUMÉ

PURPOSE: Sunitinib is a recommended drug for metastatic renal cell carcinoma (RCC). However, the therapeutic potential of sunitinib is impaired by toxicity and resistance. Therefore, we seek to explore a combinatorial strategy to improve sunitinib efficacy of low-toxicity dose for better clinical application. METHODS: We screen synergistic reagents of sunitinib from a compound library containing 1374 FDA-approved drugs by in vitro cell viability evaluation. The synergistically antiproliferative and proapoptotic effects were demonstrated on in vitro and in vivo models. The molecular mechanism was investigated by phosphoproteomics, co-immunoprecipitation, immunofluorescence and western-blot assays, etc. RESULTS: From the four-step screening, nilotinib stood out as a potential synergistic killer combined with sunitinib. Subsequent functional evaluation demonstrated that nilotinib and sunitinib synergistically inhibit RCC cell proliferation and promote apoptosis in vitro and in vivo. Mechanistically, nilotinib activates E3-ligase HUWE1 and in combination with sunitinib renders MCL-1 for degradation via proteasome pathway, resulting in the release of Beclin-1 from MCL-1/Beclin-1 complex. Subsequently, Beclin-1 induces complete autophagy flux to promote antitumor effect. CONCLUSION: Our findings revealed that a novel mechanism that nilotinib in combination with sunitinib overcomes sunitinib resistance in RCC. Therefore, this novel rational combination regimen provides a promising therapeutic avenue for metastatic RCC and rationale for evaluating this combination clinically.


Sujet(s)
Autophagie , Néphrocarcinome , Résistance aux médicaments antinéoplasiques , Tumeurs du rein , Protéine Mcl-1 , Pyrimidines , Sunitinib , Sunitinib/pharmacologie , Néphrocarcinome/traitement médicamenteux , Néphrocarcinome/métabolisme , Néphrocarcinome/anatomopathologie , Humains , Autophagie/effets des médicaments et des substances chimiques , Résistance aux médicaments antinéoplasiques/effets des médicaments et des substances chimiques , Tumeurs du rein/traitement médicamenteux , Tumeurs du rein/anatomopathologie , Tumeurs du rein/métabolisme , Lignée cellulaire tumorale , Animaux , Pyrimidines/pharmacologie , Protéine Mcl-1/métabolisme , Souris nude , Prolifération cellulaire/effets des médicaments et des substances chimiques , Synergie des médicaments , Apoptose/effets des médicaments et des substances chimiques , Tests d'activité antitumorale sur modèle de xénogreffe , Souris , Souris de lignée BALB C , Protéolyse/effets des médicaments et des substances chimiques , Bécline-1/métabolisme
6.
Int J Mol Sci ; 24(23)2023 Nov 27.
Article de Anglais | MEDLINE | ID: mdl-38069131

RÉSUMÉ

Penile cancer (PC) is a rare male malignant tumor, with early lymph node metastasis and poor prognosis. Human papillomavirus (HPV) plays a key role in the carcinogenesis of PC. This review aims to summarize the association between HPV infection and PC in terms of virus-host genome integration patterns (the disrupted regions in the HPV and PC genome), genetic alterations, and epigenetic regulation (methylation and microRNA modification) occurring in HPV and PC DNA, as well as tumor immune microenvironment reprogramming. In addition, the potential of HPV vaccination strategies for PC prevention and treatment is discussed. Understanding of the HPV-related multidimensional mechanisms and the application of HPV vaccines will promote rational and novel management of PC.


Sujet(s)
Infections à papillomavirus , Vaccins contre les papillomavirus , Tumeurs du pénis , Humains , Mâle , Femelle , Infections à papillomavirus/complications , Infections à papillomavirus/prévention et contrôle , Infections à papillomavirus/génétique , Tumeurs du pénis/prévention et contrôle , Tumeurs du pénis/génétique , Épigenèse génétique , Carcinogenèse/génétique , Vaccins contre les papillomavirus/usage thérapeutique , Papillomaviridae/génétique , Microenvironnement tumoral
7.
Acta Pharm Sin B ; 13(8): 3382-3399, 2023 Aug.
Article de Anglais | MEDLINE | ID: mdl-37655321

RÉSUMÉ

Radiotherapy is widely used in the management of advanced colorectal cancer (CRC). However, the clinical efficacy is limited by the safe irradiated dose. Sensitizing tumor cells to radiotherapy via interrupting DNA repair is a promising approach to conquering the limitation. The BRCA1-BARD1 complex has been demonstrated to play a critical role in homologous recombination (HR) DSB repair, and its functions may be affected by HERC2 or BAP1. Accumulated evidence illustrates that the ubiquitination-deubiquitination balance is involved in these processes; however, the precise mechanism for the cross-talk among these proteins in HR repair following radiation hasn't been defined. Through activity-based profiling, we identified PT33 as an active entity for HR repair suppression. Subsequently, we revealed that BAP1 serves as a novel molecular target of PT33 via a CRISPR-based deubiquitinase screen. Mechanistically, pharmacological covalent inhibition of BAP1 with PT33 recruits HERC2 to compete with BARD1 for BRCA1 interaction, interrupting HR repair. Consequently, PT33 treatment can substantially enhance the sensitivity of CRC cells to radiotherapy in vitro and in vivo. Overall, these findings provide a mechanistic basis for PT33-induced HR suppression and may guide an effective strategy to improve therapeutic gain.

8.
Adv Sci (Weinh) ; 10(27): e2300759, 2023 09.
Article de Anglais | MEDLINE | ID: mdl-37544925

RÉSUMÉ

Numerous studies have demonstrated that individual proteins can moonlight. Eukaryotic Initiation translation factor 3, f subunit (eIF3f) is involved in critical biological functions; however, its role independent of protein translation in regulating colorectal cancer (CRC) is not characterized. Here, it is demonstrated that eIF3f is upregulated in CRC tumor tissues and that both Wnt and EGF signaling pathways are participating in eIF3f's oncogenic impact on targeting phosphoglycerate dehydrogenase (PHGDH) during CRC development. Mechanistically, EGF blocks FBXW7ß-mediated PHGDH ubiquitination through GSK3ß deactivation, and eIF3f antagonizes FBXW7ß-mediated PHGDH ubiquitination through its deubiquitinating activity. Additionally, Wnt signals transcriptionally activate the expression of eIF3f, which also exerts its deubiquitinating activity toward MYC, thereby increasing MYC-mediated PHGDH transcription. Thereby, both impacts allow eIF3f to elevate the expression of PHGDH, enhancing Serine-Glycine-One-Carbon (SGOC) signaling pathway to facilitate CRC development. In summary, the study uncovers the intrinsic role and underlying molecular mechanism of eIF3f in SGOC signaling, providing novel insight into the strategies to target eIF3f-PHGDH axis in CRC.


Sujet(s)
Tumeurs colorectales , Transduction du signal , Humains , Facteur de croissance épidermique , Sérine
9.
Environ Chem Lett ; : 1-32, 2023 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-37362014

RÉSUMÉ

The rise of global waste and the decline of fossil fuels are calling for recycling waste into energy and materials. For example, rice straw, a by-product of rice cultivation, can be converted into biogas and by-products with added value, e.g., biofertilizer, yet processing rice straw is limited by the low energy content, high ash and silica, low nitrogen, high moisture, and high-quality variability. Here, we review the recycling of rice straw with focus on the global and Chinese energy situations, conversion of rice straw into energy and gas, biogas digestate management, cogeneration, biogas upgrading, bioeconomy, and life cycle assessment. The quality of rice straw can be improved by pretreatments, such as baling, ensiling, and co-digestion of rice straw with other feedstocks. The biogas digestate can be used to fertilize soils. The average annual potential energy of collectable rice straw, with a lower heating value of 15.35 megajoule/kilogram, over the past ten years (2013-2022) could reach 2.41 × 109 megajoule.

10.
J Biol Chem ; 299(7): 104854, 2023 07.
Article de Anglais | MEDLINE | ID: mdl-37224962

RÉSUMÉ

Functional depletion of the U1 small nuclear ribonucleoprotein (snRNP) with a 25 nt U1 AMO (antisense morpholino oligonucleotide) may lead to intronic premature cleavage and polyadenylation of thousands of genes, a phenomenon known as U1 snRNP telescripting; however, the underlying mechanism remains elusive. In this study, we demonstrated that U1 AMO could disrupt U1 snRNP structure both in vitro and in vivo, thereby affecting the U1 snRNP-RNAP polymerase II interaction. By performing chromatin immunoprecipitation sequencing for phosphorylation of Ser2 and Ser5 of the C-terminal domain of RPB1, the largest subunit of RNAP polymerase II, we showed that transcription elongation was disturbed upon U1 AMO treatment, with a particular high phosphorylation of Ser2 signal at intronic cryptic polyadenylation sites (PASs). In addition, we showed that core 3'processing factors CPSF/CstF are involved in the processing of intronic cryptic PAS. Their recruitment accumulated toward cryptic PASs upon U1 AMO treatment, as indicated by chromatin immunoprecipitation sequencing and individual-nucleotide resolution CrossLinking and ImmunoPrecipitation sequencing analysis. Conclusively, our data suggest that disruption of U1 snRNP structure mediated by U1 AMO provides a key for understanding the U1 telescripting mechanism.


Sujet(s)
Morpholinos , Oligonucléotides antisens , Précurseurs des ARN , Petites ribonucléoprotéines nucléaires U1 , Morpholinos/métabolisme , Oligonucléotides antisens/métabolisme , Oligonucléotides antisens/pharmacologie , Polyadénylation , Petites ribonucléoprotéines nucléaires U1/génétique , Petites ribonucléoprotéines nucléaires U1/métabolisme , RNA polymerase II/génétique , RNA polymerase II/métabolisme , Précurseurs des ARN/métabolisme , Humains , Cellules HeLa , Techniques de knock-down de gènes , Facteur de spécificité de clivage et polyadénylation , Facteur de stimulation du clivage/métabolisme , Transcription génétique/effets des médicaments et des substances chimiques
11.
Respir Res ; 24(1): 111, 2023 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-37061730

RÉSUMÉ

BACKGROUND: Non-small cell lung cancer (NSCLC) is the main type of the most common malignant tumor in the world. Previous studies have shown that the expression level of mitochondrial creatine kinase 1 (CKMT1) is abnormal in NSCLC, but the mechanism of its effect remains unclear. Therefore, in this study, we intend to clarify the potential mechanism of CKMT1 in NSCLC and provide the theoretical basis for the clinical application of CKMT1. METHODS: The function of CKMT1 in NSCLC was identified by analyzing the GEO dataset and evaluating using in vitro and in vivo models. Protein mass spectrometry was used to find proteins interacting with CKMT1, and Co-immunoprecipitation (Co-IP) and GST-pull down experiments were used to verify the interaction between proteins. The immunofluorescence (IF) assay was used to explore the functional position of CKMT1 in cells. The effect of CKMT1 expression level on the efficacy of paclitaxel (TAX) in the treatment of NSCLC was analyzed by a combined TAX experiment in vivo and in vitro. RESULTS: CKMT1 expression was increased in NSCLC and CKMT1 promoted the proliferation of NSCLC cells in vitro and in vivo. CKMT1 knockdown resulted in a significantly increased G0/G1 fraction and decreased S phase cell fraction, indicating G1 phase arrest. Mechanically, the cyclin-dependent kinase 4 (CDK4) was identified to interact with CKMT1, and the crucial binding areas were focused on the DH domain of CKMT1 and the N- and C-terminal of CDK4. A fraction of the CDK4 proteins colocalize and interact with the CKMT1 at mitochondria, the level of phosphorylated CDK4 was regulated by CKMT1. Hence, the decrease in CKMT1 expression level could increase the antitumor effect of G2/M cell cycle antagonist-TAX in NSCLC in vitro and in vivo. CONCLUSIONS: CKMT1 could interact with CDK4 in mitochondria and regulate the phosphorylated level of CDK4, thus contributing to the proliferation and cell cycle transition of NSCLC cells. And CKMT1 could be a potential target to improve the sensitivity of chemotherapy based on TAX.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Humains , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Carcinome pulmonaire non à petites cellules/génétique , Carcinome pulmonaire non à petites cellules/anatomopathologie , Cycle cellulaire , Lignée cellulaire tumorale , Prolifération cellulaire , Mitochondrial creatine kinase , Kinase-4 cycline-dépendante/génétique , Tumeurs du poumon/génétique , Tumeurs du poumon/anatomopathologie
12.
Biochem Pharmacol ; 211: 115498, 2023 05.
Article de Anglais | MEDLINE | ID: mdl-36913990

RÉSUMÉ

Despite the use of targeted therapy in non-small cell lung cancer (NSCLC) patients, cisplatin (DDP)-based chemotherapy is still the main option. However, DDP resistance is the major factor contributing to the failure of chemotherapy. In this study, we tried to screen DDP sensitizers from an FDA-approved drug library containing 1374 small-molecule drugs to overcome DDP resistance in NSCLC. As a result, disulfiram (DSF) was identified as a DDP sensitizer: DSF and DDP had synergistic anti-NSCLC effects, which are mainly reflected in inhibiting tumor cell proliferation, plate colony formation and 3D spheroidogenesis and inducing apoptosis in vitro, as well as the growth of NSCLC xenografts in mice. Although DSF has recently been reported to promote the antitumor effect of DDP by inhibiting ALDH activity or modulating some important factors or pathways, unexpectedly, we found that DSF reacted with DDP to form a new platinum chelate, Pt(DDTC)3+, which might be one of the important mechanisms for their synergistic effect. Moreover, Pt(DDTC)3+ has a stronger anti-NSCLC effect than DDP, and its antitumor activity is broad-spectrum. These findings reveal a novel mechanism underlying the synergistic antitumor effect of DDP and DSF, and provide a drug candidate or a lead compound for the development of a new antitumor drug.


Sujet(s)
Antinéoplasiques , Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Humains , Souris , Animaux , Cisplatine/pharmacologie , Cisplatine/métabolisme , Disulfirame/pharmacologie , Platine/pharmacologie , Carcinome pulmonaire non à petites cellules/métabolisme , Tumeurs du poumon/métabolisme , Antinéoplasiques/pharmacologie , Prolifération cellulaire , Résistance aux médicaments antinéoplasiques , Lignée cellulaire tumorale
13.
Open Life Sci ; 18(1): 20220551, 2023.
Article de Anglais | MEDLINE | ID: mdl-36816800

RÉSUMÉ

This study investigated the effect of combined thymosin α1 and vitamin C (Tα1 + VitC) on the immunological responses of septic rats. Five groups were designed. The septic model was established by the cecal ligation puncture (CLP) method. The sham group did not undergo CLP, the model group was given normal saline solution, the Tα1 group was given Tα1 (200 µg/kg), the VitC group was given VitC (200 mg/kg), and the Tα1 + VitC group was given Tα1 + VitC. Specimens for immunological analyses were collected at 6, 12, 24, and 48 h posttreatment in each group except for the sham group (only at 48 h). CD4 + CD25 + T cells in the peripheral blood and dendritic cell (DC) proportions in the spleen were analyzed by flow cytometry. Tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), transforming growth factor-ß (TGF-ß1), and nuclear factor kappa-B (NF-κB) were measured by ELISA. CD4 + CD25 + T cells and OX62 + DCs levels significantly increased in the model group and decreased in the Tα1 and/or VitC treatment groups. Similarly, the levels of TNF-α, IL-6, TGF-ß1, and NF-κB significantly increased in the model group and decreased in the Tα1, VitC, and Tα1 + VitC groups, indicating that combined Tα1 and VitC therapy may help regulate the immunological state of patients with sepsis, thereby improving prognosis.

14.
Chinese Pharmacological Bulletin ; (12): 153-160, 2023.
Article de Chinois | WPRIM (Pacifique Occidental) | ID: wpr-1013892

RÉSUMÉ

Aim To study the anti-inflammatory activ¬ity of diterpenes from Tripterygium wilfordii on lipopo- lysaccharide ( LPS)-induced macrophage and its mech¬anism. Methods MTT assay was used to detect the cytotoxicity of compounds. The Griess method was used to detect the NO on LPS-induced RAW264. 7 cells. ELISA was applied to determine the contents of inter- leukin 6 (IL-6) , tumor necrosis factor a ( TNF-a ) , interleukin lp (IL-lfj) and interleukin 18 (IL-18) in cell culture supernatant. Western blot was used to de¬tect IkBcx, .INK, ERK, p38, STAT3 and their phos-phorylation in LPS-induced RAW264.7, as well as the effect on COX-2, iNOS, NLRP3, caspase-1 , cleaved- caspase-1. Flow cytometry was employed to detect the effects of compounds on the phagocytosis of RAW 264. 7 cells. Results Hypoglicin II (1) and ent-pimara-8 (14) , 15-diene-19-ol (6) , two diterpenoid compounds from Tripterygium wilfordii could effectively inhibit the expression of inflammatory mediators ( COX-2 and iN- OS) and inflammatory cytokines (IL-6, IL-lp, IL- 18) in LPS-induced RAW264. 7 cells. Further re¬search found that the phosphorylation of IkBcx , JNK, ERK, P38, STAT3 and NLRP3 was all inhibited; however, there was no significant effect on the expres¬sion of IkBcx, JNK, ERK, P38 and STAT3. At the same time, they also inhibited the phagocytosis of mac-rophages. Conclusions The anti-inflammatory mecha¬nism of Tripterygium wilfordii diterpenoids 1 and 6 might be through inhibiting the production of NLRP3 inflammatory bodies, inflammatory mediators (COX-2 and iNOS) and inflammatory cytokines (IL-6, IL-lp and IL-18) , which is closely related to inhibiting the activation of MAPK, NF-kB and STAT3 pathway.

15.
Acta Pharmaceutica Sinica B ; (6): 3382-3399, 2023.
Article de Anglais | WPRIM (Pacifique Occidental) | ID: wpr-1011119

RÉSUMÉ

Radiotherapy is widely used in the management of advanced colorectal cancer (CRC). However, the clinical efficacy is limited by the safe irradiated dose. Sensitizing tumor cells to radiotherapy via interrupting DNA repair is a promising approach to conquering the limitation. The BRCA1-BARD1 complex has been demonstrated to play a critical role in homologous recombination (HR) DSB repair, and its functions may be affected by HERC2 or BAP1. Accumulated evidence illustrates that the ubiquitination-deubiquitination balance is involved in these processes; however, the precise mechanism for the cross-talk among these proteins in HR repair following radiation hasn't been defined. Through activity-based profiling, we identified PT33 as an active entity for HR repair suppression. Subsequently, we revealed that BAP1 serves as a novel molecular target of PT33 via a CRISPR-based deubiquitinase screen. Mechanistically, pharmacological covalent inhibition of BAP1 with PT33 recruits HERC2 to compete with BARD1 for BRCA1 interaction, interrupting HR repair. Consequently, PT33 treatment can substantially enhance the sensitivity of CRC cells to radiotherapy in vitro and in vivo. Overall, these findings provide a mechanistic basis for PT33-induced HR suppression and may guide an effective strategy to improve therapeutic gain.

16.
Shanghai Kou Qiang Yi Xue ; 32(6): 609-614, 2023 Dec.
Article de Chinois | MEDLINE | ID: mdl-38494969

RÉSUMÉ

PURPOSE: To investigate the prognosis of advanced oral squamous cell carcinoma (AOSCC) patients undergoing neck dissection with sternocleidomastoid muscle (SCM) preservation and resection. METHODS: From January 2013 to June 2017, a total of 235 AOSCC patients(stage Ⅲ and stage Ⅳ) who were diagnosed and underwent neck dissection at the Department of Oral and Maxillofacial Surgery, College and Hospital of Stomatology, Guangxi Medical University, were collected and followed-up. The differences in overall survival(OS), local recurrence-free survival (LRFS) and regional recurrence-free survival (RRFS) were compared between different surgical procedures. SPSS 25.0 software package was used for statistical analysis. RESULTS: Among 235 patients with postoperative follow-up, 101 patients retained the SCM during operation, and 134 patients had SCM removed. There was no significant difference in 5-year survival rate and 5-year regional recurrence rate between the SCM preservation group and the SCM resection group. Kaplan-Meier method of univariate analysis showed that SCM preservation or resection had no significant difference in OS, LRFS and RRFS. Cox multivariate regression analysis results showed that there was no significant difference between different surgical procedures in OS, LRFS and RRFS, while N stage and postoperative chemoradiotherapy were independent influencing factors for OS, LRFS and RRFS in AOSCC patients. CONCLUSIONS: Neck dissection with SCM preservation in AOSCC patients has no effect on survival and recurrence (including local recurrence and regional recurrence). It is feasible for AOSCC patients to undergo SCM-preserving neck dissection when metastatic cervical lymph nodes do not invade SCM. N stage and postoperative chemoradiotherapy affect the prognosis of AOSCC patients.


Sujet(s)
Carcinome épidermoïde , Tumeurs de la tête et du cou , Tumeurs de la bouche , Humains , Évidement ganglionnaire cervical/méthodes , Carcinome épidermoïde de la tête et du cou/anatomopathologie , Carcinome épidermoïde/chirurgie , Carcinome épidermoïde/anatomopathologie , Tumeurs de la bouche/chirurgie , Tumeurs de la bouche/anatomopathologie , Études rétrospectives , Chine , Pronostic , Études de cohortes , Tumeurs de la tête et du cou/chirurgie , Tumeurs de la tête et du cou/anatomopathologie , Muscles/anatomopathologie , Récidive tumorale locale/anatomopathologie , Récidive tumorale locale/chirurgie , Stadification tumorale
17.
Mol Ther Oncolytics ; 26: 330-346, 2022 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-36090478

RÉSUMÉ

The use of radiotherapy for hypopharyngeal cancer (HC) treatment is increasing, and it is currently the primary treatment option for this cancer. However, radioresistance occurs in a proportion of patients. Here, we found that radiation increased proteasomal gene expression and that proteasome assembly was dependent on the induction of transcription factor NRF1 in HC. Through screening assays, we identified a mechanism by which proteasome-mediated degradation of DEP domain-containing mTOR-interacting protein (DEPTOR) contributes to the elevation of mTORC1 signaling after radiation. Therefore, after treatment with proteasome inhibitors (PIs), stabilization of DEPTOR inhibited mTORC1 signaling elevated by radiation and ultimately sensitized HC to radiotherapy. Mechanically, PIs not only interrupted the deubiquitination and degradation of DEPTOR but also suppressed the ubiquitination of DEPTOR mediated by ß-TrCP. Clinically, the high levels of DEPTOR in HC cells were associated with sensitivity to radiotherapy and favorable prognosis. Stabilizing DEPTOR through targeting proteasome-mediated degradation is a potential strategy for sensitizing HC to radiotherapy.

18.
J Environ Manage ; 320: 115895, 2022 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-35944326

RÉSUMÉ

Digestate generated from anaerobic digestion (AD) has been widely used as digestate fertilizer (DF) for plant growth, but its application should be comprehensively investigated. This study evaluates the effects of different amounts of DF on crop growth, nutrient use efficiency (NUE), soil properties, and potential negative impacts of DF application (salinity and heavy metals (HMs)) with two different crops (Eggplant and Shanghai cabbage). In eggplant cultivation, the yield increased with the increase of DF amount, and the yield of the DF-680 group was the highest (65.4 t/ha) under the highest fertilizer amount. However, due to high ammonia volatilization loss and excessive application, the NUE of DF was only about half of that of chemical fertilizer (CF). Significantly different from eggplant, the high application amount of DF resulted in yield reduction in Shanghai cabbage cultivation. The yield and NUE of the DF-170 group were the highest, the yield was 46.5 t/ha, and the NUE was more than twice compared to CF. Moreover, DF can raise soil nitrogen storage and alleviate soil acidification caused by fertilization in both batches of cultivation. Nevertheless, the electrical conductivity (EC) value of the soil was increased by 2-3 times, and the long-term application may lead to soil salinization. On the other hand, the increase of DF application elevated the content of copper (Cu), zinc (Zn), and cadmium (Cd) in soil significantly but did not cause HMs contamination in crops and tillage soil. In summary, reasonable application amounts and methods should be considered when applying DF.


Sujet(s)
Engrais , Métaux lourds , Agriculture/méthodes , Chine , Produits agricoles , Engrais/analyse , Métaux lourds/analyse , Azote/analyse , Appréciation des risques , Sol/composition chimique , Légumes
19.
RNA Biol ; 19(1): 686-702, 2022.
Article de Anglais | MEDLINE | ID: mdl-35491945

RÉSUMÉ

It has recently been shown that CFIm25, a canonical mRNA 3' processing factor, could play a variety of physiological roles through its molecular function in the regulation of mRNA alternative polyadenylation (APA). Here, we used CRISPR/Cas9-mediated gene editing approach in human embryonic stem cells (hESCs) for CFIm25, and obtained three gene knockdown/mutant cell lines. CFIm25 gene editing resulted in higher proliferation rate and impaired differentiation potential for hESCs, with these effects likely to be directly regulated by the target genes, including the pluripotency factor rex1. Mechanistically, we unexpected found that perturbation in CFIm25 gene expression did not significantly affect cellular mRNA 3' processing efficiency and APA profile. Rather, we provided evidences that CFIm25 may impact RNA polymerase II (RNAPII) occupancy at the body of transcribed genes, and promote the expression level of a group of transcripts associated with cellular proliferation and/or differentiation. Taken together, these results reveal novel mechanisms underlying CFIm25's modulation in determination of cell fate, and provide evidence that the process of mammalian gene transcription may be regulated by an mRNA 3' processing factor.


Sujet(s)
Polyadénylation , Cellules souches , Animaux , Techniques de knock-down de gènes , Humains , Mammifères/génétique , ARN messager/génétique , ARN messager/métabolisme , Facteurs de clivage et de polyadénylation de l'ARN messager/métabolisme
20.
Environ Res ; 212(Pt D): 113404, 2022 09.
Article de Anglais | MEDLINE | ID: mdl-35568236

RÉSUMÉ

Bioenergy is a promising solution for greenhouse gas (GHG) emissions mitigation. However, the emissions resulting from the different production stages must be quantified and evaluated. The life cycle assessment (LCA) method was used to compare and quantify the environmental burdens of three rice straw (RS) utilization scenarios for producing biogas, briquette fuel, and syngas. To our knowledge, this is the first study that applies the LCA approach to assess these three bioenergy scenarios in a single study where the main goal was to determine the most sustainable option. A total of 10 mid-point impact categories were investigated. The results indicated that the three scenarios achieved net positive energy and net negative GHG balances. The briquette fuel scenarios had the highest net energy balance (11,115 MJ/tonne dry RS), while the syngas scenario had the highest net GHG (-2,315 kg CO2-eq./tonne dry RS). Moreover, the syngas scenario was the most beneficial to the environment, achieving negative results in 9 out of the 10 impact categories; the largest was marine ecotoxicity (-853,897 kg 1,4-DB-eq./tonne dry RS). The biogas scenario achieved emission savings in 3 out of the 10 categories. Although the briquette fuel scenario had no negative values in the 10 categories, its overall contribution to environmental burdens was relatively low. Overall, the order of the three scenarios in terms of the most sustainable option is syngas > briquette fuel > biogas.


Sujet(s)
Gaz à effet de serre , Oryza , Animaux , Biocarburants , Effet de serre , Étapes du cycle de vie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE